-+ 0.00%
-+ 0.00%
-+ 0.00%
On November 2, Changshan Pharmaceutical stated on an interactive platform that the company currently has no patents for albumin-coupled dual-target GLP-1 and albumin-coupled three-target GLP-1.
Share
Listen to the news
On November 2, Changshan Pharmaceutical stated on an interactive platform that the company currently has no patents for albumin-coupled dual-target GLP-1 and albumin-coupled three-target GLP-1.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending